DrugPatentWatch Database Preview
Drugs in Development Information for Quinacrine
What is the drug development status for Quinacrine?
Quinacrine is an investigational drug.
There have been 9 clinical trials for Quinacrine.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2005.
The most common disease conditions in clinical trials are Glioblastoma, Carcinoma, Non-Small-Cell Lung, and Creutzfeldt-Jakob Syndrome. The leading clinical trial sponsors are Cleveland BioLabs, University of California, San Francisco, and Milton S. Hershey Medical Center.
Summary for Quinacrine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,966 |
| WIPO Patent Applications | 2,458 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 3 (2005-01-01) |
| Vendors | 24 |
Recent Clinical Trials for Quinacrine
| Title | Sponsor | Phase |
|---|---|---|
| The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak | National Taiwan University Hospital | N/A |
| Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinoma | Milton S. Hershey Medical Center | Phase 1/Phase 2 |
| Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer | Neelesh Sharma MD PhD | Phase 1 |
Clinical Trial Summary for Quinacrine
Top disease conditions for Quinacrine
Top clinical trial sponsors for Quinacrine
US Patents for Quinacrine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
